Cyclolab Ltd strengthens its position in the market1 Jul 2019
Cyclolab Ltd. is an R&D and cGMP manufacturing company focusing on all aspects of cyclodextrin science, manufacturing and applications for cyclodextrin, Dexolve, Sugammadex, formulation development, custom synthesis, Niemann Pick C.
The Cyclolab Cyclodextrin R&D Laboratory is the world's only all-round cyclodextrin biotech company and has operated as a small R&D company for over 25 years.
Recent changes in the world market and economy revealed the need for a change in the company’s business portfolio, which is why we have decided to share the resources between R&D activity and establishment of manufacturing facilities that enable the production of cyclodextrins in larger scale under GMP circumstances.
To maintain and strengthen our position in the market, CycloLab dedicates special attention to invention and developing patentable technologies, highlighted by the over 130 patents filed by the company so far.
CycloLab committed its operations to serve the pharmaceutical industry by participating in early phase drug development studies (feasibility, formulation optimization, bioequivalence, etc), analysis and GMP manufacturing of various cyclodextrin derivatives to be applied as excipients as well as exploring new applications of CDs such as proteins stabilization, non-viral gene delivery or re-discovery as APIs for several therapeutic areas.
Our goal is to help our partners in the successful development of cyclodextrin-based products via supply of the highest quality cyclodextrins and providing services (analytical, formulation development, custom synthesis or GMP manufacturing). We discover proprietary applications for cyclodextrins and join in collaborations, or out-license these to other companies.
Study demonstrates potential of blood test for early lung cancer detection
16 Sep 2019
Ground-breaking trial demonstrates potential of blood test which harnesses the power of the immune system to reduce late detection of lung cancer.Read more
M2i Life Sciences completes a historic fundraising of 60 million Euros
16 Sep 2019
To support its strong growth, M2i Life Sciences has concluded a capital increase of 60 million Euros with five leading investors (ADM Capital, Eurazeo Growth, Téthys Invest, Creadev and France 2i fund managed by RAISE Impact).Read more
FUJIFILM Irvine Scientific launches BalanCD Gal Supplement for biotherapeutic development
10 Sep 2019
Delivers enhanced galactosylation for improved protein quality, and antibody binding and function.Read more
BioCity backs world's first Rx to OTC switch incubator
5 Sep 2019
Maxwellia considered to have the skills and the expertise to deliver and reach their goal of creating the big OTC brands of the future.Read more
Dutch company receives €20 million for skin cancer diagnostic test
3 Sep 2019
The test can accurately predict the risk of having metastases present in the lymph nodes without having to undergo surgery to remove lymph nodes.Read more
AbbVie axes Rovalpituzumab Tesirine R&D program
2 Sep 2019
Independent Data Monitoring Committee recommended terminating the study due to lack of survival benefit.Read more
Improving anxiety-induced insomnia with lavender oil
29 Aug 2019
New data shows pharmaceutical-quality lavender oil significantly improves anxiety-induced insomnia when taken as a daily capsule.Read more
Grant from Innovate UK to fund gel stabilisation technologies development
28 Aug 2019
Atelerix Consortium awarded £267,000 Innovate UK Grant for collaboration with the Cell and Gene Therapy Catapult and Rexgenero on cell therapy stabilisation technologies.Read more
Exciting new vaccine targets killer disease TB
28 Aug 2019
Australian researchers produce early-stage vaccine which is inhaled into the lungs.Read more
Rapid adoption of Carterra’s LSA instrument drives European expansion
20 Aug 2019
Company's antibody screening platform minimizes the risk of missing a blockbuster.Read more
Are you a supplier
Here's what we can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation